Kindred Biosciences to Participate in Stifel Virtual Healthcare Conference and A.G.P. Virtual Healthcare Symposium
Kindred Biosciences (NASDAQ: KIN) will present at the Stifel Virtual Healthcare Conference on November 17 and participate in the A.G.P. Virtual Healthcare Symposium on November 19. CEO Dr. Richard Chin will hold one-on-one meetings to discuss recent developments and study results from key therapeutic programs. The Stifel conference presentation is scheduled from 2:40–3:10 PM ET. Archived webcasts will be available for 30 days. KindredBio is committed to developing safe and effective therapeutics for pets.
- None.
- None.
SAN FRANCISCO, Nov. 11, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Stifel Virtual Healthcare Conference on November 17 and participate in the A.G.P. Virtual Healthcare Symposium on November 19.
Dr. Richard Chin, Chief Executive Officer, will be available for one-on-one meetings. During this time, investors will have the opportunity to discuss recent developments, study results from key therapeutic programs in development, and upcoming milestones.
Conference Details:
Stifel Virtual Healthcare Conference
Date: November 17, 2020
Presentation time: 2:40–3:10p.m. ET
Webcast URL: Click here
A.G.P. Virtual Healthcare Symposium
Date: November 19, 2020
An archived version of the above webcasts will be available for 30 days on the KindredBio website.
About Kindred Biosciences
Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company's strategy is to identify targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated targets for dogs and cats. KindredBio has a deep pipeline of novel biologics in development across many therapeutic classes, alongside state-of-the-art biologics manufacturing capabilities and a broad intellectual property portfolio.
For more information, visit: www.kindredbio.com
Contact
Katja Buhrer
katja.buhrer@kindredbio.com
(917) 969-3438
View original content to download multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-participate-in-stifel-virtual-healthcare-conference-and-agp-virtual-healthcare-symposium-301170380.html
SOURCE Kindred Biosciences, Inc.
FAQ
What is the date of Kindred Biosciences' presentation at the Stifel Virtual Healthcare Conference?
When will Kindred Biosciences participate in the A.G.P. Virtual Healthcare Symposium?
What time is the Stifel Virtual Healthcare Conference presentation for KIN?
Who is the CEO of Kindred Biosciences?
Where can I find the archived webcasts for Kindred Biosciences' conferences?
